Product Search

User Login






Register Here

Order Status

Your Cart is currently empty.

I-GLK (Glucokinase Isoform 1)

PDFPrintE-mail

Description:

Glucokinase (Hexokinase 4) (GCK), transcript variant 1(I-GLK) (Cat# R5051)
Species Human
Expression Host E.coli
Tag His- tag
Purity 95%
Molecular Weight 53.2 kDa.
Gene Accession Number NM_000162.


View Full Specifications
SKUPrice
P5051 $283.80
:
 

Purification and Quality Control   The His-tag recombinant protein is purified by affinity chromatography in combination with FPLC columns.  The purified I-GLK (isoform 1) is greater than 95% homogeneous based on SDS-PAGE analysis.
 Unit Definition (Activity) 1 unit equals 1 nanogram of purified protein.
 Applications Can be used for the phosphorylation of Glucose; kit development.
 Formulation and Storage The protein is in 20mM Tris-HCl pH7.9,100mM NaCl, 0.2mM EDTA, 1mM DTT and 20% glycerol. Stored at -70°C before use. Avoid repeated freeze thaw cycles.
 Synonym homo sapiens glucokinase (hexokinase 4) (GCK), transcript variant 1; FGQTL3; GK; GLK; HHF3; HK4; HKIV; HXKP; LGLK and MODY2.
 Protein Sequence MLDDRARMEA AKKEKVEQIL AEFQLQEEDL KKVMRRMQKE MDRGLRLETH EEASVKMLPT
YVRSTPEGSE VGDFLSLDLG GTNFRVMLVK VGEGEEGQWS VKTKHQMYSI PEDAMTGTAE
MLFDYISECI SDFLDKHQMK HKKLPLGFTF SFPVRHEDID KGILLNWTKG FKASGAEGNN
VVGLLRDAIK RRGDFEMDVV AMVNDTVATM ISCYYEDHQC EVGMIVGTGC NACYMEEMQN
VELVEGDEGR MCVNTEWGAF GDSGELDEFL LEYDRLVDES SANPGQQLYE KLIGGKYMGE
LVRLVLLRLV DENLLFHGEA SEQLRTRGAF ETRFVSQVES DTGDRKQIYN ILSTLGLRPS
TTDCDIVRRA CESVSTRAAH MCSAGLAGVI NRMRESRSED VMRITVGVDG SVYKLHPSFK
ERFHASVRRL TPSCEITFIE SEEGSGRGAA LVSAVACKKA CMLGQ
 Background Glucokinase is a structurally and functionally unique member of the hexokinase family. Glucokinase is expressed only in mammalian liver and pancreatic islet beta cells. Because of its unique functional characteristics, the enzyme plays an important regulatory role in glucose metabolism. Defects in the glucokinase gene have long been suspected contributors to the genetic susceptibility to noninsulin-dependent diabetes mellitus.(1) It is suggested that mutant GCK leads to chronic hyperglycemia by raising the threshold of circulating glucose levels which induces insulin secretion. (2) Given the central role of glucokinase in the regulation of insulin release, it is understandable that mutations in the GCK gene can cause both hyper- and hypoglycemia. (3)Recently, a novel class of drugs that stimulate the GK molecule directly have been discovered, which offer a new principle for drug therapy of diabetes. (4)
 References 1. Matsutani, A. et al, Genomics 12: 319-325, 1992.
2. Velho, G. et al, Lancet 340: 444-448, 1992.
3. Gloyn, A. L., et al. Hum. Mutat. 22: 353-362, 2003.
4. Grimsby, J. et al., Diabetes 50 (Suppl.2), A115, 2001.


Recently Viewed Products

-->
Content View Hits : 73447